Which phosphodiesterase can decrease cardiac effects of 5-HT 4 receptor activation in transgenic mice?

作者: Joachim Neumann , Benedikt Käufler , Ulrich Gergs

DOI: 10.1007/S00210-019-01653-Y

关键词:

摘要: Serotonin (5-hydroxy-tryptamine, 5-HT) exerted concentration-dependent positive inotropic effects or chronotropic in transgenic (TG) mice which overexpress the human 5-HT4a receptor heart but not littermate wild-type (WT) mice. These and are thought to be mediated by cyclic adenosine 3′,5′-monophosphate (cAMP) TG cardiomyocytes. To determine whether these antagonized endogenous phosphodiesterases (PDEs), of 5-HT were tested additional presence PDE inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA) (1 μM, a PDE2 inhibitor) cilostamide PDE3 inhibitor), rolipram (0.1 μM 1 μM, PDE4 their combinations. For comparison, 3-isobutyl-1-methylxanthine (IBMX), an unspecific inhibitor, was investigated. The use 10 μM IBMX, combination (1 μM) EHNA (1 μM), (0.1 μM) each increased potency elevate force contraction mice, increase beating rate This indicates that regulate In contrast, alone, decreased summary, our present data suggest effect does involve activities, whereas basal diminished activity PDE4. Phosphorylation PDE4, when is inhibited, might enhance

参考文章(42)
F Afzal, K W Andressen, H K Mørk, J M Aronsen, I Sjaastad, C P Dahl, T Skomedal, F O Levy, J-B Osnes, E Qvigstad, 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles. British Journal of Pharmacology. ,vol. 155, pp. 1005- 1014 ,(2009) , 10.1038/BJP.2008.339
Ø Ørstavik, S H Ata, J Riise, C P Dahl, G Ø Andersen, F O Levy, T Skomedal, J-B Osnes, E Qvigstad, Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart. British Journal of Pharmacology. ,vol. 171, pp. 5169- 5181 ,(2014) , 10.1111/BPH.12647
Alejandro Galindo-Tovar, María Luisa Vargas, Alberto J. Kaumann, Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE1 in mice Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 389, pp. 177- 186 ,(2016) , 10.1007/S00210-015-1178-2
Roya Zoraghi, Jackie D. Corbin, Sharron H. Francis, Phosphodiesterase-5 Gln817 Is Critical for cGMP, Vardenafil, or Sildenafil Affinity ITS ORIENTATION IMPACTS cGMP BUT NOT cAMP AFFINITY Journal of Biological Chemistry. ,vol. 281, pp. 5553- 5558 ,(2006) , 10.1074/JBC.M510372200
Donald H. Maurice, Hengming Ke, Faiyaz Ahmad, Yousheng Wang, Jay Chung, Vincent C. Manganiello, Advances in targeting cyclic nucleotide phosphodiesterases Nature Reviews Drug Discovery. ,vol. 13, pp. 290- 314 ,(2014) , 10.1038/NRD4228
S. H. Soderling, S. J. Bayuga, J. A. Beavo, Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 7071- 7076 ,(1999) , 10.1073/PNAS.96.12.7071
Sabine Weninger, Joris H. De Maeyer, Romain A. Lefebvre, Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 386, pp. 671- 684 ,(2013) , 10.1007/S00210-013-0855-2
Alejandro Galindo-Tovar, Maria Luisa Vargas, Elisa Escudero, Alberto J. Kaumann, Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT4 receptors British Journal of Pharmacology. ,vol. 156, pp. 237- 249 ,(2009) , 10.1111/J.1476-5381.2008.00023.X
S. Weninger, K. Van Craenenbroeck, R.T. Cameron, F. Vandeput, M.A. Movsesian, G.S. Baillie, R.A. Lefebvre, Phosphodiesterase 4 interacts with the 5-HT4(b) receptor to regulate cAMP signaling Cellular Signalling. ,vol. 26, pp. 2573- 2582 ,(2014) , 10.1016/J.CELLSIG.2014.07.027